Sitagliptin phosphate monohydrate / simvastatin
Key facts
Active substance |
|
Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
Decision number |
P/172/2009
|
PIP number |
Sitagliptin phosphate monohydrate / simvastatin
|
Pharmaceutical form(s) |
Film-coated tablet
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|